gene	chromosome	start	end	applicableMutationType	source	sourceEvent	sourceUrls	studyNctId	studyTitle	countriesOfStudy	treatment	sourceRelevantTreatmentApproaches	relevantTreatmentApproaches	applicableCancerType	applicableDoid	blacklistCancerTypes	level	direction	evidenceUrls
BRAF	7	140453136	140453137	MISSENSE	CKB_EVIDENCE	600X					Vemurafenib			Skin Melanoma	X		A	RESPONSIVE	http
BRAF	7	140453136	140453137	MISSENSE	CKB_TRIAL	600X	NCT1	study1	netherlands		Vemurafenib			Breast cancer	X		A	RESPONSIVE	http